Individuals with germline BRCA1 mutations have a 57‒72% lifetime probability of developing breast cancer, whereas those with germline BRCA2 mutations have a 45‒69% lifetime probability [6–8]. This evidence concerns the gene BRCA1 and breast carcinoma.